Hanako Furukori - Concepedia

Author

Hanako Furukori

Hirosaki University

Also Known As

Furukori H, H FURUKORI, H Furukori, H Furukori, M.D., H. Furukori, Hanako Furukori, hanako Furukori

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Hirosaki University Yamagata University Akebono (Japan)Hirosakiaiseikai Hospital Hirosaki University Hospital

About

Hanako Furukori is an author at Hirosaki University specializing in medicine, pharmacology, and psychiatry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	716
2	Social Sciences	4	4	174
3	Health Sciences	1	1	84
4	Nursing	1	1	87
5	Biochemistry	1	1	10

Hanako Furukori

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Relationship between occupational stress and depression among psychiatric nurses in Japan Kaori Yoshizawa, Norio Sugawara, Norio Yasui‐Furukori, Archives of Environmental & Occupational Health Psychiatric NursesMental HealthWorker HealthSocial SciencesNursing Practice	2014	87
Prevalence of metabolic syndrome among patients with schizophrenia in Japan Norio Sugawara, Norio Yasui‐Furukori, Yasushi Sato, Schizophrenia Research ObesityMetabolic SyndromeBody CompositionMetabolic DisorderPsychiatry	2010	84
Dose-Dependent Effects of Adjunctive Treatment With Aripiprazole on Hyperprolactinemia Induced by Risperidone in Female Patients With Schizophrenia Norio Yasui‐Furukori, Hanako Furukori, Norio Sugawara, Journal of Clinical Psychopharmacology Hyperprolactinemia InducedLow DosagePsychiatryDose-dependent EffectsPsychotropic Medication	2010	72
Effects of the allele on the steady-state plasma concentrations of haloperidol and reduced haloperidol in Japanese patients with schizophrenia Kiyoshi Mihara, A SUZUKI, Tadashi Kondo, Clinical Pharmacology & Therapeutics	1999	70
The –141C Ins/Del polymorphism in the dopamine D2 receptor gene promoter region is associated with anxiolytic and antidepressive effects during treatment with dopamine antagonists in schizophrenic patients Akihito Suzuki, Tsuyoshi Kondo, Kazuo Mihara, Pharmacogenetics	2001	67
Significant pharmacokinetic interaction between risperidone and carbamazepine: its relationship with CYP2D6 genotypes Shingo Ono, Kazuo Mihara, Akihito Suzuki, Psychopharmacology Cyp2d6 GenotypesPharmacologyPharmacogenomicsPharmacotherapySignificant Pharmacokinetic Interaction	2002	66
Effect of itraconazole on the single oral dose pharmacokinetics and pharmacodynamics of alprazolam Norio Yasui, Tsuyoshi Kondo, Koichi Otani, Psychopharmacology Medicinal ChemistryPharmacological StudyPharmacologyPharmacotherapyMedicine	1998	59
Work&ndash;family conflict as a mediator between occupational stress and psychological health among mental health nurses in Japan Norio Sugawara, Kazuma Danjo, Hanako Furukori, Neuropsychiatric Disease and Treatment	2017	57
Effect of Carbamazepine on the Single Oral Dose Pharmacokinetics of Alprazolam Hanako Furukori Neuropsychopharmacology Pharmacological StudyMedicineNeuropharmacologyPharmacotherapyPharmacology	1998	49
Determination of risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography: application to therapeutic drug monitoring in Japanese patients with schizophrenia T. Nagasaki, Tadashi Ohkubo, Kazunobu Sugawara, Journal of Pharmaceutical and Biomedical Analysis Therapeutic Drug MonitoringPsychiatryPharmacologyPsychopharmacologySchizophrenia	1999	46

Page 1